Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07400146 · ClinicalTrials.gov registry record · Phase 4
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT07400146 is a Phase 4 study that has not yet begun recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT07400146, a Phase 4 study, has not yet begun recruiting, sponsored by Cedars-Sinai Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Postoperative shoulder pain is often reported to be particularly bothersome after laparoscopy. The benefits of local anesthetic, such as bupivacaine, applied to subcutaneous tissue for general postoperative pain management after surgery is well established. However, there have been no studies on sprayed bupivacaine over the diaphragm to reduce shoulder pain in laparoscopic surgery. The purpose of the study is to evaluate if sprayed infra-diaphragmatic bupivacaine compared to placebo (saline) will improve postoperative shoulder pain in patients undergoing benign laparoscopic gynecologic surgery. The entire study will be conducted at Cedar Sinai Medical Center.
Interventions
- DRUG Instillation of Bupivacaine with epinephrine over the diaphragm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07400146
The ClinicalTrials.gov registry entry for NCT07400146 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Instillation of Bupivacaine with epinephrine over the diaphragm is the first listed.
NCT07400146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07400146 about?
NCT07400146 is a clinical study titled "Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy". Postoperative shoulder pain is often reported to be particularly bothersome after laparoscopy. The benefits of local anesthetic, such as bupivacaine, applied to subcutaneous tissue for general postoperative pain management after surgery is well established. However, there have been no studies on spr...
What is the current status of trial NCT07400146?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2026-02. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07400146?
The interventions under investigation include: Instillation of Bupivacaine with epinephrine over the diaphragm (DRUG).
Who is sponsoring clinical trial NCT07400146?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.